The apparent disconnect between the in vitro and in vivo effects of disrupting PSEN1 and γ-secretase support the need for stringent in vivo models as we seek to unravel the immunology of complex diseases such as multiple sclerosis. Here, PSEN1 is linked to multiple sclerosis.